Kulkarni Swanand Sanjay (Swanand Kulkarni)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Combination Therapy

Preterm Infants

Virtual Reality

Top Venues

Journal of biomolecular structure & dynamics

Current medicinal chemistry

Medical oncology (Northwood, London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Kulkarni Swanand Sanjay, Yogesh Singh, Avadh Biharee, Neha Bhatia, Vikram Deep Monga, Suresh Thareja
Molecular docking, 3D-QSAR and simulation studies for identifying pharmacophoric features of indole derivatives as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5) inhibitors. Journal of biomolecular structure & dynamics (2023)
Rakesh Khator, Avadh Biharee, Neha Bhatia, Kulkarni Swanand Sanjay, Yogesh Singh, Chandrabose Karthikeyan, Akhlesh Kumar Jain, Suresh Thareja
Medicinal Aspects of PTP 1B Inhibitors as Anti-Breast Cancer Agents: An Overview. Current medicinal chemistry (2023)
Kulkarni Swanand Sanjay, Yogesh Singh, Avadh Biharee, Neha Bhatia, Vikram Deep Monga, Suresh Thareja
Molecular docking, 3D-QSAR and simulation studies for identifying pharmacophoric features of indole derivatives as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5) inhibitors. Journal of biomolecular structure & dynamics (2023)
Yogesh Singh, Niraj Kumar, Kulkarni Swanand Sanjay, Satwinder Singh, Suresh Thareja
Pharmacophore derived 3D-QSAR, molecular docking, and simulation studies of quinoxaline derivatives as ALR2 inhibitors. Journal of biomolecular structure & dynamics (2023)
Avadh Biharee, Arpita Yadav, Kailash Jangid, Yogesh Singh, Kulkarni Swanand Sanjay, Devesh M Sawant, Pradeep Kumar, Suresh Thareja, Akhlesh Kumar Jain
Flavonoids as promising anticancer agents: an in silico investigation of ADMET, binding affinity by molecular docking and molecular dynamics simulations. Journal of biomolecular structure & dynamics (2022)
Pooja Ratre, Kulkarni Swanand Sanjay, Sweety Das, Chengyuan Liang, Pradyumna Kumar Mishra, Suresh Thareja
Medicinal chemistry aspects and synthetic strategies of coumarin as aromatase inhibitors: an overview. Medical oncology (Northwood, London, England) 40 (1) (2022)
Yogesh Singh, Kulkarni Swanand Sanjay, Pradeep Kumar, Satwinder Singh, Suresh Thareja
Molecular dynamics and 3D-QSAR studies on indazole derivatives as HIF-1α inhibitors. Journal of biomolecular structure & dynamics (2022)